Insights

Equity and dilution are the twin forces that shape every founder’s economic outcome. From the moment a startup issues its first shares to the day it exits, the interplay between giving up equity (to investors, employees, and partners) and building value determines whether founding a company is financially transformative or merely a learning experience. Yet many founders enter fundraising negotiations with only a surface-level understanding of how equity dilution works — and the cumulative cost of that knowledge gap can be millions of euros in lost ownership. This guide explains the mechanics of startup equity and dilution in practical terms: how ownership changes with each funding round, how to model the long-term impact of dilution, and how to make informed decisions that protect founder economics through multiple rounds of financing. What Is Equity in a Startup? Equity represents ownership in a company. When founders incorporate a startup, they issue shares — typically ordinary shares (common stock) — that represent 100% ownership. As the company grows and raises capital, new shares are issued to investors, employees, and other stakeholders, changing the ownership distribution. Startup equity exists in several forms. Ordinary shares (common stock) are held by founders and employees. Preferred shares are issued to investors at each funding round and carry additional rights — liquidation preferences, anti-dilution protection, and governance rights — that ordinary shares do not. Stock options give employees the right to purchase shares at a predetermined price (the exercise or strike price) after they vest. Warrants are similar to options but are typically issued to lenders or strategic partners. The critical distinction is between basic ownership (shares currently issued and outstanding) and fully diluted ownership (all issued shares plus all shares that could be issued through options, warrants, and convertible instruments). Investors always think in fully diluted terms, and founders should too. How Dilution Works Dilution occurs whenever new shares are issued, reducing the percentage ownership of existing shareholders. It is a mathematical certainty of raising external capital — and it is not inherently negative. Dilution in exchange for capital that increases the company’s value is a good trade; dilution on unfavourable terms or without corresponding value creation is destructive. The basic dilution formula is: New Ownership % = Old Ownership % × (Old Shares / New Total Shares). If a founder owns 60% of 10 million shares and a new round issues 2.5 million shares to investors, the founder’s ownership drops to 60% × (10M / 12.5M) = 48%. Dilution happens at multiple points during a startup’s life: when co-founders receive their shares (splitting the initial 100%), when advisers receive equity, when the employee stock option pool (ESOP) is created or expanded, at each funding round when new shares are issued to investors, and when convertible instruments (SAFEs, convertible notes) convert into equity. A Typical Dilution Journey Understanding the cumulative impact of dilution across multiple rounds is essential for long-term planning. A realistic European startup dilution trajectory for a two-founder company might look like this: Incorporation: Two co-founders split 100% ownership (50/50 or 60/40). Combined founder ownership: 100%. Pre-seed / Advisers: 2-5% allocated to early advisers and a small initial ESOP. Founder ownership: 95-98%. Seed round: Investors receive 15-25% of the company. If an ESOP is expanded to 10%, the combined dilution from seed investors and the ESOP reduces founder ownership to approximately 65-75%. Series A: Investors receive 15-25%. The ESOP may be topped up to 12-15%. Post-Series A, founders typically retain 40-55% combined ownership. Series B: Another 10-20% dilution from new investors, plus potential ESOP expansion. Post-Series B, founders typically hold 30-45% combined. Series C and beyond: Continued dilution, though typically at smaller percentages as valuations increase. By the time a company reaches Series C, founders may hold 20-35% combined — which, at a company valued at €200 million or more, represents very significant economic value. The Option Pool Shuffle One of the most impactful — and least understood — dilution events occurs not when investors buy shares, but when the employee option pool is created or expanded. At Series A and beyond, investors typically require that the ESOP be carved out of the pre-money valuation, meaning the dilution falls entirely on existing shareholders (founders and seed investors), not on the new investors. The practical impact is significant. A company with a stated €20 million pre-money valuation that must create a 12% ESOP from the pre-money is effectively giving founders a lower real valuation. The €20 million pre-money includes the ESOP, so the implied value of the existing shares is closer to €17.6 million. Founders who negotiate a larger option pool than they actually need are diluting themselves unnecessarily. The optimal approach is to size the ESOP based on your actual hiring plan for the next 18-24 months. If you can demonstrate that you need a 10% pool rather than a 15% pool (with a detailed hiring plan showing specific roles and equity allocations), you save 5 percentage points of dilution — which at a €20 million valuation represents €1 million in founder value. Anti-Dilution Protection Anti-dilution provisions are investor protections that adjust their ownership if the company raises a future round at a lower valuation (a “down round”). These provisions can significantly amplify dilution for founders in adverse scenarios. Broad-based weighted average is the standard and most founder-friendly form. It adjusts the investor’s conversion price based on the weighted average of the old and new prices, taking into account all outstanding shares. The adjustment is proportional and relatively modest. Narrow-based weighted average uses a smaller denominator (only certain share classes) in the calculation, resulting in a larger adjustment and more dilution for founders. It is less common but still encountered. Full ratchet is the most aggressive form — it adjusts the investor’s conversion price to the exact price of the down round, regardless of the amount raised. This can dramatically increase investor ownership at the expense of founders and employees. Full ratchet provisions should be resisted in all but the most exceptional circumstances. Protecting […]

Runway — the number of months a startup can operate before it runs out of cash — is the most fundamental metric in startup survival. Every strategic decision a founder makes is constrained by runway: when to hire, when to fundraise, whether to pursue growth or efficiency, and when to pivot. Yet many founders track their runway only loosely, relying on back-of-the-envelope calculations that miss critical variables. This guide provides a rigorous framework for calculating, extending, and managing your startup’s runway. Understanding runway is not just about knowing when the money runs out. It is about making better decisions every month — decisions that optimise the balance between growth and survival, between ambition and prudence. How to Calculate Startup Runway The basic runway formula is straightforward: Runway (months) = Cash Balance / Monthly Net Burn Rate. If a company has €1.2 million in the bank and spends a net €100,000 per month more than it earns, it has 12 months of runway. However, the simplicity of this formula masks important nuances. The first is the distinction between gross burn and net burn. Gross burn is the total monthly expenditure — salaries, rent, software, marketing, everything. Net burn subtracts revenue from gross burn. A company with €150,000 in monthly expenses and €50,000 in monthly revenue has a gross burn of €150,000 and a net burn of €100,000. The second nuance is that burn rate is rarely constant. Hiring plans, seasonal revenue patterns, one-off expenses (office moves, conference sponsorships, equipment purchases), and annual payments (insurance, software licenses) all cause the burn rate to fluctuate month to month. A more accurate runway calculation uses a forward-looking cash flow model that projects monthly inflows and outflows for the next 12-24 months, accounting for planned hires, known commitments, and expected revenue growth. The Runway Framework: Red, Amber, Green Experienced operators and investors use a traffic-light framework to assess runway health. The thresholds below are guidelines, not rigid rules, but they reflect the consensus among European VCs and CFOs. Green (18+ months). The company is in a strong position. There is ample time to execute on the current plan, hit milestones, and fundraise from a position of strength. Strategic hiring and growth investments can proceed with confidence. Amber (9-18 months). The company should be actively planning its next fundraise. If the plan is to raise equity, the process should begin when runway hits 12 months — fundraising typically takes 3-6 months, and you want to close with at least 6 months of cash remaining. If the plan is to reach profitability, the path must be clearly mapped with specific milestones. Red (under 9 months). Urgent action is required. If a fundraise is not already in progress, the company should immediately reduce burn rate (hiring freezes, discretionary spending cuts) and explore all capital options — equity, venture debt, bridge loans, or revenue-based financing. Fundraising from a position of desperation leads to unfavourable terms, down rounds, or failure. Building a Cash Flow Model A proper runway model goes beyond the simple division formula. It is a month-by-month projection of all cash inflows and outflows, typically built in a spreadsheet with three scenarios: base case, optimistic case, and conservative case. Revenue projections should be based on current run rate, pipeline, and historical conversion rates — not aspirational targets. For the conservative case, assume flat or modest growth. For the optimistic case, assume your sales targets are met. The base case should be your honest best estimate. Expense projections should include every committed cost: current salaries (including employer taxes and benefits, which in Europe can add 25-45% to the gross salary), rent, software subscriptions, professional services, and planned hires with their expected start dates. Do not forget one-off costs: VAT payments, annual insurance renewals, equipment purchases, and conference or travel budgets. Working capital effects matter for companies with significant accounts receivable or accounts payable. A company that invoices enterprise customers on net-60 terms may show strong revenue on the P&L but experience cash inflows 60-90 days after the sale. The cash flow model must account for this timing gap. Strategies to Extend Runway When runway is shorter than desired, founders have several levers to extend it — each with different trade-offs. Reduce burn rate. The most direct approach. Common measures include slowing or freezing hiring, renegotiating vendor contracts, reducing discretionary spending (travel, events, marketing experiments), and in severe cases, salary reductions or layoffs. The key is to cut without destroying the company’s ability to hit the milestones needed for the next round. Accelerate revenue. Offering annual prepayment discounts (pay 12 months upfront for a 15-20% discount), launching a new pricing tier, or focusing sales efforts on quick-close deals can bring cash forward. For SaaS companies, shifting from monthly to annual billing can dramatically improve cash flow. Raise non-dilutive capital. European founders have access to a rich ecosystem of grants, subsidies, and tax incentives that US companies do not. Government innovation grants (Bpifrance, Innovate UK, EIC Accelerator), R&D tax credits (the French CIR, the UK R&D tax relief), and regional development funds can provide meaningful capital with zero dilution. The trade-off is time — grant applications can take months to process. Revenue-based financing. For companies with predictable recurring revenue, revenue-based financing (RBF) provides capital in exchange for a percentage of future revenue until a predetermined amount is repaid. European providers include Capchase, Re:cap, and Uncapped. RBF is non-dilutive and faster than equity fundraising, but the effective cost of capital can be high. Venture debt. As covered in our separate venture debt guide, adding a debt facility alongside or after an equity round can extend runway by 6-12 months with minimal dilution (typically 0.5-2% in warrants). Runway and Fundraising Timing The relationship between runway and fundraising timing is critical. Starting a fundraise too late — with less than 6 months of runway — forces founders into a weak negotiating position. Investors can sense desperation, and they either extract aggressive terms or pass entirely. The optimal time to begin fundraising is when […]

Startup valuation is one of the most debated and least understood aspects of the fundraising process. Unlike mature companies that can be valued based on cash flows, earnings multiples, or asset values, early-stage startups often have minimal revenue, no profits, and uncertain futures. Yet every funding round requires a valuation — a number that determines how much of the company investors receive for their capital and how much founders retain. Understanding the methods, benchmarks, and negotiation dynamics of startup valuation is essential for any founder entering a fundraising process. This guide covers the main valuation methods used at each stage, the benchmarks that European investors apply, and the practical strategies for negotiating a fair valuation that serves both founders and investors. Why Startup Valuation Matters Valuation directly determines dilution — the percentage of the company that founders give up in exchange for capital. A higher valuation means less dilution for the same amount of money raised. However, valuation is not simply “higher is better.” An inflated valuation creates expectations that must be met at the next round; failing to grow into the valuation leads to a down round, which damages morale, triggers anti-dilution provisions, and signals weakness to the market. The optimal valuation is one that fairly reflects the company’s current progress and near-term potential, attracts high-quality investors, and sets a realistic bar for the next funding milestone. Experienced founders and investors refer to this as a “Goldilocks valuation” — not too high, not too low. Valuation Methods for Early-Stage Startups Several methods are used to value startups at different stages. No single method is definitive — in practice, valuations are determined by a combination of methodology, market conditions, and negotiation dynamics. The Berkus Method is one of the simplest frameworks for pre-revenue startups. Developed by angel investor Dave Berkus, it assigns value (up to €500,000 each) to five key risk factors: the quality of the idea, the founding team, the existence of a working prototype, strategic relationships, and evidence of early traction or sales. The maximum pre-money valuation under the Berkus method is €2.5 million, making it suitable for pre-seed and very early seed valuations. Comparable transactions (or “comps”) are the most common method for seed and Series A valuations. This approach looks at what similar companies raised at similar stages and applies those benchmarks. If comparable SaaS companies in Europe are raising Series A rounds at 15-25x ARR, a company with €1 million ARR might expect a pre-money valuation of €15-25 million. The challenge lies in finding truly comparable transactions — sector, geography, growth rate, and market conditions all affect the comparison. Revenue multiples become the dominant method from Series A onward. SaaS companies are typically valued at a multiple of ARR (annual recurring revenue), with the multiple determined by growth rate, retention metrics, gross margins, and market opportunity. High-growth European SaaS companies (100%+ year-over-year growth) might command 20-40x ARR, while steady-growth businesses (30-50% YoY) trade at 8-15x. Marketplace businesses are often valued on a multiple of gross merchandise value (GMV) or net revenue. Discounted cash flow (DCF) analysis is theoretically the most rigorous method but is rarely used for early-stage startups due to the enormous uncertainty in projecting future cash flows. DCF becomes more relevant at growth stage (Series C+) and pre-IPO, where the business model is proven and financial projections are more reliable. Scorecard method adjusts average seed-stage valuations based on specific factors. Starting with the average seed valuation in the relevant market (for example, €4 million in Western Europe), the method applies weighted adjustments for team strength (25% weight), market size (20%), product stage (15%), competitive environment (10%), and other factors. This produces a customised valuation grounded in market averages. European Valuation Benchmarks by Stage While every company is unique, the following ranges represent typical European valuations in 2026. These are medians — outliers exist in both directions. Pre-seed: €1 million – €3 million pre-money. At this stage, valuation is driven almost entirely by team quality, market potential, and the investor’s assessment of risk. Pre-seed valuations vary less by sector and more by geography and investor profile. Seed: €3 million – €8 million pre-money. Companies with a working product and early traction command the higher end. AI, deeptech, and climate startups with strong IP or regulatory moats may exceed this range. Seed valuations have increased by approximately 30% over the past three years across Europe. Series A: €10 million – €30 million pre-money. The range widens significantly at this stage because Series A valuations are anchored to revenue metrics. A SaaS company with €1.5 million ARR growing at 150% annually will command a materially different valuation than one growing at 50%. Series B: €30 million – €100 million pre-money. Growth rate, market position, and path to profitability drive valuations at this stage. The gap between top-quartile and median companies widens considerably. Factors That Drive Valuation Up or Down Beyond the baseline metrics, several factors can significantly influence a startup’s valuation in either direction. Growth rate is the single most powerful driver. A company growing at 3x year-over-year will typically command 2-3x the valuation multiple of a company growing at 1.5x, even with similar absolute revenue. Investors are buying future value, and growth rate is the strongest predictor of future scale. Net revenue retention (NRR) above 120% signals that existing customers are expanding their usage — a strong indicator of product-market fit and a predictor of efficient future growth. Companies with NRR above 130% command premium valuations because each cohort of customers becomes more valuable over time. Competitive dynamics in the fundraise itself matter enormously. A company with three term sheets will achieve a higher valuation than an identical company with one. Creating competitive tension — by running a structured process with multiple interested funds moving in parallel — is the single most effective negotiation lever available to founders. Market conditions fluctuate significantly. In hot markets, valuations rise across the board as more capital chases fewer deals. In downturns, even strong companies may need to […]

Venture debt has emerged as one of the most important complementary financing tools in the European startup ecosystem. Unlike equity funding, which requires founders to sell ownership in their company, venture debt provides capital as a loan — allowing startups to extend their runway, finance specific growth initiatives, or bridge to the next equity round without additional dilution. For venture-backed companies with predictable revenue or clear milestones ahead, venture debt can be a strategically powerful addition to the capital structure. Yet venture debt remains poorly understood by many European founders, who often view it as either a sign of weakness (unable to raise equity) or an unnecessary complication. Neither perception is accurate. Used correctly, venture debt is a tool of financial sophistication — and the European venture debt market has matured significantly, with dedicated providers, standardised terms, and a growing track record of successful deployments. What Is Venture Debt? Venture debt is a form of debt financing specifically designed for venture-capital-backed startups. Unlike traditional bank loans, which require collateral, profitability, and years of financial history, venture debt is underwritten primarily on the strength of the company’s VC backers, its growth trajectory, and its ability to raise future equity rounds. Venture debt typically takes the form of a term loan with a fixed interest rate, a repayment schedule of 24-48 months, and warrants — small equity stakes (typically 0.5-2% of the company) that give the lender upside participation if the company succeeds. The combination of interest payments and warrants makes venture debt more expensive than traditional bank debt but significantly cheaper than equity in terms of dilution. A typical venture debt facility is sized at 25-50% of the most recent equity round. A company that has just raised a €10 million Series A might secure €3-5 million in venture debt alongside or shortly after the equity round. The debt extends the company’s runway by 6-12 months and provides capital for specific initiatives without requiring the founders to raise a larger (and more dilutive) equity round. When to Use Venture Debt Venture debt is most valuable in specific strategic situations. The most common use case is runway extension — adding 6-12 months of operating capital after an equity round to give the company more time to hit milestones before the next raise. This is particularly valuable when the company is close to a significant inflection point (reaching profitability, closing a major contract, or achieving a regulatory milestone) that would meaningfully increase its valuation. Growth financing is another common application. If a company has proven unit economics and needs capital to scale a specific channel (hiring a sales team, expanding into a new market, investing in marketing), venture debt can fund that growth without the months-long distraction of an equity fundraise. This is particularly relevant for SaaS companies with strong net revenue retention, where each incremental customer is clearly accretive. Bridge financing — using debt to bridge between equity rounds when the timing is not ideal — is a valid but riskier use case. If the company is genuinely close to its next fundraise and needs a few months of additional runway, a bridge loan can be appropriate. However, using venture debt to paper over fundamental problems (missed targets, declining growth) is dangerous — it adds a repayment obligation to a company that may already be struggling. Key Terms and Structure Understanding the standard terms of a venture debt facility is essential for evaluating whether a specific offer is competitive. Interest rate. Venture debt typically carries interest rates of 8-14%, depending on the company’s stage, the lender, and market conditions. Rates may be fixed or floating (tied to a benchmark like EURIBOR or SOFR plus a spread). Some facilities include a payment-in-kind (PIK) component, where a portion of the interest accrues rather than being paid in cash — preserving cash flow but increasing the total cost. Warrants. Lenders typically receive warrants to purchase shares equal to 0.5-2% of the company’s fully diluted equity. The warrant strike price is usually set at the price of the most recent equity round. Warrants add dilution, but significantly less than a comparable equity raise would. Covenants. Venture debt agreements include financial covenants — conditions the company must maintain throughout the loan term. Common covenants include minimum cash balance requirements, revenue milestones, and restrictions on additional debt. Breaching a covenant can trigger an event of default, giving the lender the right to accelerate repayment. Draw-down structure. Many venture debt facilities are structured as revolving lines of credit or tranched loans, where the company can draw capital as needed within a specified period (typically 6-12 months). This flexibility means the company only pays interest on capital it actually uses. Venture Debt Providers in Europe The European venture debt market has expanded significantly, with both dedicated venture lenders and traditional financial institutions now actively serving the startup ecosystem. Dedicated venture debt funds include Kreos Capital (one of Europe’s oldest and largest, now part of BlackRock), Bootstrap Europe, Columbia Lake Partners, and Claret Capital Partners. These funds specialise exclusively in lending to VC-backed companies and understand the unique dynamics of startup growth. Public institutions play a uniquely European role. The European Investment Bank (EIB) and its venture debt programme provide large-scale facilities (often €15-50 million) to growth-stage European startups at competitive rates. National development banks — Bpifrance, the British Business Bank, and KfW — also offer venture lending programmes, sometimes on highly favourable terms. Commercial banks have increasingly entered the space. Silicon Valley Bank (now part of First Citizens) maintains a European presence, while HSBC Innovation Banking (formerly SVB UK) and Stifel serve the UK market. European banks like ABN AMRO and ING have also developed startup lending programmes. Risks and Considerations Venture debt is not free money — it carries real risks that founders must understand before signing a facility agreement. The most fundamental risk is the repayment obligation. Unlike equity, which never needs to be repaid, debt must be serviced. If the company’s growth stalls or a subsequent […]

A cap table — short for capitalisation table — is the single most important financial document a startup founder will maintain from day one through to exit. It records who owns what in the company: every share, every option, every convertible instrument, and every vesting schedule. Yet many founders treat their cap table as an afterthought until a Series A investor asks to see it — and discover that years of informal agreements, uncleaned conversions, and poorly tracked option grants have created a mess that takes weeks and thousands in legal fees to untangle. This guide covers everything founders need to know about building, maintaining, and optimising their cap table from incorporation through to growth stage — with particular attention to the European context where multi-jurisdiction structures and local instruments add complexity. What Is a Cap Table? A capitalisation table is a detailed ledger of all equity ownership in a company. At its simplest, it lists every shareholder, the number of shares they own, the class of shares, and their percentage ownership. As the company grows, the cap table expands to include stock options (both vested and unvested), warrants, convertible notes, SAFEs, and any other instruments that could convert into equity. The cap table serves multiple purposes. It is the foundation for fundraising conversations — investors need to understand the existing ownership structure before they can model what their investment will buy. It governs voting rights and governance decisions. It determines how proceeds are distributed in an exit. And it is the basis for tax calculations on equity compensation for employees. A well-maintained cap table should answer several key questions at any moment: who owns what percentage of the company, what is the fully diluted ownership (including all options and convertible instruments), how would a new investment round affect existing shareholders, and how would exit proceeds be distributed at various valuations. Building Your Cap Table From Day One The cap table begins at incorporation. When founders set up the company, they issue the initial shares — typically split among the co-founders according to an agreed ratio. The most common mistake at this stage is not having a frank conversation about equity splits and vesting early. Equal splits among co-founders are simple but not always appropriate; the equity split should reflect each founder’s contribution, commitment, and role. Founder vesting is essential even among co-founders who trust each other implicitly. A standard four-year vesting schedule with a one-year cliff ensures that if a co-founder leaves early, the remaining team retains an appropriate share of the equity. Without vesting, a co-founder who departs after six months could walk away with 33% or 50% of the company — a “dead equity” problem that poisons future fundraising. Share classes. At incorporation, founders typically hold ordinary shares (common stock). When institutional investors come in at seed or Series A, they receive preferred shares — a different class with specific rights (liquidation preferences, anti-dilution protection, governance rights). The cap table must track each class separately, as they carry different economic and governance rights. Initial structure. A clean cap table at incorporation might look like this: 10,000,000 ordinary shares split among 2-3 founders, with a vesting schedule attached to each. Some founders also reserve shares for an early advisor pool (1-3%) and begin setting up an employee stock option plan (ESOP), though the ESOP is often formally created later. How Funding Rounds Affect Your Cap Table Each funding round changes the cap table by issuing new shares to investors, which dilutes existing shareholders proportionally. Understanding this dilution math is critical for founders who want to maintain meaningful ownership through multiple rounds. Pre-money vs post-money valuation. The pre-money valuation is what the company is worth before the new investment. The post-money valuation is the pre-money plus the new capital. If a company has a €10 million pre-money valuation and raises €2.5 million, the post-money is €12.5 million, and the new investors own 20% (€2.5M / €12.5M). All existing shareholders are diluted by 20% — a founder who held 60% now holds 48%. Option pool creation. Series A investors typically require the company to establish or expand an employee stock option pool (ESOP) before the round closes, usually sized at 10-15% of fully diluted shares. Critically, this pool is created from the pre-money valuation — meaning the dilution from the option pool falls on existing shareholders (founders and seed investors), not on the new Series A investors. This is one of the most misunderstood mechanics in startup fundraising and can have a significant impact on effective valuation. Convertible instrument conversion. When SAFEs and convertible notes convert at a priced round, they add additional shares to the cap table. If a company has raised €1 million in SAFEs with a €5 million cap, and the Series A is priced at €10 million pre-money, the SAFEs convert at the €5 million cap — giving SAFE holders a larger percentage than if they had invested at the Series A price. Modelling these conversions accurately before a fundraise is essential to avoid surprises. The Employee Stock Option Pool An employee stock option pool (ESOP) is a reserved block of shares set aside for current and future employees. Options give employees the right to purchase shares at a predetermined price (the “strike price” or “exercise price”) after they vest, typically over four years with a one-year cliff. The ESOP is a critical tool for attracting and retaining talent, particularly in the competitive European tech market where startups cannot always match the salaries offered by large corporations. However, the ESOP also affects the cap table in important ways — every option granted represents potential dilution for all other shareholders. European ESOP structures vary by jurisdiction. In France, the BSPCE (Bons de Souscription de Parts de Créateur d’Entreprise) is a tax-efficient equity incentive scheme specifically designed for startup employees. The UK has EMI (Enterprise Management Incentive) options with favourable tax treatment. Germany has historically been less friendly to employee equity, though recent reforms have improved the […]

Early-stage fundraising rarely begins with a traditional priced equity round. Instead, most pre-seed and seed investments are structured using one of two instruments: SAFE notes (Simple Agreement for Future Equity) or convertible notes. Both allow startups to raise capital quickly without the cost and complexity of a full valuation negotiation — but they work differently, carry different risks, and are better suited to different situations. Understanding these instruments, along with the term sheets that govern later priced rounds, is essential knowledge for any founder raising capital. This guide explains how each instrument works, when to use it, what to negotiate, and how they interact with your cap table — with specific attention to how European practice differs from the US. What Is a SAFE Note? A SAFE (Simple Agreement for Future Equity) is an investment contract created by Y Combinator in 2013 to simplify early-stage fundraising. It is not debt — there is no interest rate, no maturity date, and no repayment obligation. Instead, a SAFE gives the investor the right to receive equity in the company at a future date, typically when the company raises a priced round (such as a Series A). The elegance of the SAFE is its simplicity. The standard Y Combinator SAFE is a five-page document with minimal negotiation points. There are no lawyers’ fees to negotiate complex terms, no board seats, and no ongoing governance obligations. For founders raising a quick pre-seed or seed round, a SAFE is the fastest path from handshake to wire transfer. How SAFEs convert. When the company raises a subsequent priced round (the “qualifying financing”), the SAFE converts into equity — specifically, into the same class of shares issued in that round (typically Series A Preferred). The conversion price is determined by the terms negotiated in the SAFE, usually a valuation cap and/or a discount rate. Valuation cap. The cap sets the maximum valuation at which the SAFE converts. If the SAFE has a €5 million cap and the Series A is priced at €15 million pre-money, the SAFE investor converts at €5 million — giving them significantly more shares per euro invested than the Series A investors. The cap protects early investors from excessive dilution if the company’s valuation increases substantially between the SAFE and the priced round. Discount rate. Some SAFEs include a discount (typically 15-25%) applied to the price of the next round. If the Series A price per share is €10 and the SAFE has a 20% discount, the SAFE converts at €8 per share. Discounts can be used alone or in combination with a cap, in which case the investor gets whichever method produces the lower conversion price. What Is a Convertible Note? A convertible note is a short-term debt instrument that converts into equity at a future financing event. Unlike a SAFE, it is technically a loan — it carries an interest rate (typically 4-8% annually), has a maturity date (usually 18-24 months), and creates a legal obligation for the company to either repay the note or convert it to equity. Convertible notes predate SAFEs by many years and remain widely used globally, particularly in Europe. The conversion mechanics are similar to SAFEs — the note converts at the next priced round, subject to a valuation cap and/or discount. However, the accrued interest on the note also converts, slightly increasing the investor’s ownership. Maturity date implications. If the company has not raised a qualifying round by the maturity date, the note technically becomes due and payable. In practice, most founders and investors negotiate an extension rather than force repayment (which would likely bankrupt an early-stage startup). However, the maturity date gives investors leverage — and savvy investors use it to negotiate additional terms at extension. Interest accrual. While the interest rates on convertible notes are modest (4-8%), the accrued interest converts to equity alongside the principal, slightly increasing the investor’s stake. On a €500,000 note at 6% over 18 months, the investor would convert €545,000 — not a dramatic difference, but it adds up across multiple notes. SAFE vs Convertible Note: When to Use Each The choice between a SAFE and a convertible note depends on jurisdiction, investor preferences, and the specific circumstances of the raise. SAFEs are best suited for very early rounds (pre-seed and early seed) where speed is paramount and the investor base is primarily angels or seed funds familiar with the instrument. SAFEs are standard in the US, increasingly common in the UK and Nordics, and gaining traction across continental Europe. Their simplicity keeps legal costs low (often under €2,000) and allows founders to close individual investors independently over weeks, rather than needing to coordinate a single close. Convertible notes are preferred in many European jurisdictions where the legal framework is better established for debt instruments. Germany, France, Switzerland, and the Benelux countries have well-developed convertible loan structures that local lawyers and investors understand deeply. France has its own variant — the BSA-AIR — which functions similarly to a SAFE but is adapted to French corporate law. Convertible notes are also preferred by investors who want the additional protection of a maturity date and interest accrual. Practical considerations. If your investors are predominantly US-based or from the global angel/accelerator ecosystem, SAFEs are the path of least resistance. If your investors are European funds or local angels, ask what they typically use — forcing an unfamiliar instrument on investors slows the process and increases legal costs. Key Terms to Negotiate Whether using a SAFE or a convertible note, the most important terms to negotiate are the valuation cap and the discount rate. These determine how much of the company early investors will own when the instrument converts. Setting the cap too low gives early investors an outsized stake and can create problems at Series A — incoming investors may demand the cap table be cleaned up, or may reduce their offer to compensate for the existing overhang. Setting the cap too high defeats the purpose of the instrument, as […]

Raising a seed round in Europe has never been more accessible — or more competitive. The continent’s seed ecosystem has expanded dramatically over the past five years, with hundreds of dedicated seed funds, active angel networks, and accelerator programmes creating a dense funding infrastructure that rivals the United States for early-stage founders. Yet the European seed landscape has its own distinct characteristics, and founders who understand its nuances raise faster and on better terms. This guide covers the practical mechanics of raising seed funding in Europe: where the money is, what investors expect, how to structure your round, and the regional differences that shape the European seed experience. Whether you are based in Paris, Berlin, Stockholm, or Tallinn, the fundamentals are consistent — but the local flavour matters. The European Seed Landscape in 2026 Europe’s seed-stage investment activity has matured into a well-functioning market. Median seed round sizes have grown from €500,000 five years ago to approximately €1.5 million to €2.5 million in 2026, with outliers reaching €4 million or more for exceptional teams in hot sectors like AI, defence tech, and climate. The increase reflects both the growing ambition of European founders and the deeper pockets of a new generation of European seed funds. The ecosystem is also more geographically distributed than ever. While London, Paris, and Berlin remain the largest hubs by deal volume, cities like Amsterdam, Stockholm, Copenhagen, Helsinki, Lisbon, Madrid, and Tallinn have each developed thriving seed-stage communities with local investors, incubators, and talent pools. This decentralisation is one of Europe’s strengths — founders can build world-class companies without relocating to a single dominant hub. Types of Seed Investors in Europe Understanding the different types of seed investors — and what each brings beyond capital — is essential for building the right cap table. Dedicated seed funds are the backbone of the European seed ecosystem. These are institutional venture funds that invest exclusively (or primarily) at the seed stage, typically writing initial cheques of €250,000 to €1.5 million. Leading European seed funds include Seedcamp (pan-European), LocalGlobe (London-based, pan-European reach), Point Nine Capital (Berlin, focused on B2B SaaS and marketplaces), Stride VC (London), Kima Ventures (Paris, one of the world’s most active seed investors by volume), and Tiny VC (Nordics). These funds bring pattern recognition, operational support, and — critically — strong networks to help with follow-on fundraising. Angel investors and syndicates play a particularly important role in European seed rounds. Unlike the US, where seed rounds are often led entirely by institutional funds, European seed rounds frequently include a mix of angels and funds. Active angel networks include FJ Labs (global but active in Europe), various national business angel associations, and syndicate platforms such as SeedBlink (strong in CEE and Southern Europe), Leapfunder (Netherlands), and AngelList equivalents in each market. Accelerators and incubators remain important entry points for first-time founders. Y Combinator accepts a growing number of European teams, while Techstars runs programmes across several European cities. European-native programmes like Entrepreneur First (London, Paris, Berlin, Bangalore), Station F (Paris), and Antler (pan-European) provide pre-seed capital (typically €50,000 to €150,000) alongside structured mentorship and investor introductions. Government and public funding is a distinctly European advantage. Bpifrance, the British Business Bank, KfW Capital (Germany), CDTI (Spain), and the European Innovation Council (EIC) all provide grants, loans, or co-investment alongside private capital. Smart founders layer public funding with private investment to reduce dilution and extend runway. What European Seed Investors Expect European seed investors have become more sophisticated and more demanding. The bar has risen from “great idea, strong team” to “great idea, strong team, and early evidence.” The specific expectations vary by sector, but the core requirements are consistent. A working product. Pure idea-stage fundraising is increasingly rare at seed. Most European seed investors expect to see at least an MVP — a functional product that real users or customers have interacted with. For B2B startups, this often means a handful of pilot customers or letters of intent. For consumer products, it means early user data showing engagement and retention. Founder-market fit. Why are you the right team to solve this problem? European investors place high value on domain expertise — founders who have worked in the industry they are disrupting, who understand the regulatory landscape, or who have technical depth that creates a genuine moat. A clear European advantage. Building in Europe is not a disadvantage — it is increasingly a strategy. European founders can leverage strong technical talent pools, lower burn rates than Silicon Valley, proximity to enterprise customers in the world’s largest single market (the EU), and a regulatory environment that increasingly favours European solutions (GDPR, AI Act, data sovereignty). Structuring Your European Seed Round The mechanics of structuring a seed round in Europe differ from the US in several important ways. Instrument choice. While SAFE notes (originated by Y Combinator) have become more common in Europe, convertible notes remain widely used, particularly in continental European jurisdictions where the legal framework is more accommodating to debt instruments. Some jurisdictions also have specific instruments — France has the BSA-AIR (similar to a SAFE), and Germany has convertible loans that are well-established in local practice. For priced rounds, seed-stage term sheets are typically lighter than Series A terms, with simpler governance and fewer investor protections. Valuation expectations. European seed valuations typically range from €3 million to €8 million pre-money, depending on the market, sector, and team track record. AI and deeptech startups with strong IP may command higher valuations. As a rule, European seed valuations are approximately 20-30% lower than comparable US rounds, though this gap has narrowed significantly in recent years. Round composition. A typical European seed round is assembled over 4-8 weeks and might include one institutional seed fund (as lead), one or two additional small funds, and several angels. The lead investor anchors the round with the largest cheque and typically sets the terms, while co-investors fill the remainder. Having a respected lead investor signals quality and makes it significantly easier to close […]

Series A funding represents the most critical inflection point in a startup’s journey — the moment when a promising early-stage company must prove it can become a scalable business. With a median European Series A now sitting between €5 million and €10 million, the stakes are higher than ever, and the bar for what investors expect has risen sharply. This playbook covers everything founders need to know about raising a Series A round in today’s market. Unlike seed rounds, where investors bet largely on the team and the vision, Series A funding demands evidence. Product-market fit must be demonstrated, not just claimed. Revenue metrics need to tell a clear growth story. And the founding team must show they can execute on a credible plan to scale. Understanding what Series A investors look for — and how to position your company for the raise — is the difference between closing a competitive round and spending months in fundraising limbo. What Is Series A Funding? Series A is typically the first institutional venture capital round with a priced equity structure. While seed rounds are often raised on SAFEs or convertible notes with light governance, Series A introduces formal term sheets, board seats, liquidation preferences, and detailed shareholder agreements. The “Series A” label refers to the class of preferred shares issued to investors — Series A Preferred Stock — which carries specific rights and protections. In practical terms, a Series A round typically ranges from €3 million to €15 million in Europe, with the median hovering around €7 million. The round is led by one institutional VC fund (the “lead investor”), which sets the terms, conducts the deepest due diligence, and usually takes a board seat. Other investors — earlier seed investors, angels, or co-investing funds — may participate alongside the lead. The capital raised at Series A funds the transition from early traction to scalable growth. Typical uses include expanding the engineering and product team, building a structured sales and marketing operation, entering new markets, and professionalising the company’s infrastructure. When Is the Right Time to Raise a Series A? Timing a Series A raise is as much art as science, but there are clear signals that indicate readiness. Raising too early — before the metrics justify the valuation — leads to painful down rounds or failed fundraises. Raising too late — after the company has run dangerously low on cash — weakens negotiating leverage. The strongest signal is consistent revenue growth. For B2B SaaS companies, this typically means reaching €500,000 to €2 million in annual recurring revenue (ARR) with month-over-month growth rates of 15-20% or more. For marketplace or consumer businesses, the equivalent might be strong unit economics, high retention rates, and evidence of network effects beginning to compound. Beyond revenue, investors look for product-market fit indicators: low churn, high NPS scores, organic word-of-mouth growth, and a sales cycle that is becoming more predictable. If customers are actively pulling the product rather than needing heavy sales effort to push it, that is a strong signal. Runway is the practical constraint. Most advisers recommend beginning the Series A process when you have 9-12 months of cash remaining. The fundraising process itself typically takes 3-6 months from first meeting to wire transfer, and you want to negotiate from a position of strength rather than desperation. What Series A Investors Look For Series A investors are evaluating a fundamentally different question than seed investors. At seed, the question is “could this work?” At Series A, the question is “is this working, and can it scale?” The criteria reflect this shift. Proven product-market fit. This is non-negotiable. Investors want to see that real customers are paying for the product, using it regularly, and deriving measurable value. Vanity metrics — downloads, page views, free signups — are insufficient. Revenue, retention, and expansion metrics matter. A credible path to scale. Series A investors are not just funding the current state of the business; they are funding the next two to three years of growth. They want to see a clear go-to-market strategy, an understanding of customer acquisition costs (CAC) and lifetime value (LTV), and a roadmap for how the capital will be deployed to accelerate growth. A strong founding team. At this stage, the team needs to demonstrate not just vision but execution capability. Have they shipped product on time? Have they closed enterprise deals? Can they recruit top talent? Investors also assess whether the team has the right composition for the next phase — a technical co-founder, a commercial lead, and increasingly a senior hire with scaling experience. Market size and timing. The total addressable market (TAM) needs to be large enough to justify a venture-scale outcome. Investors are looking for markets worth at least €1 billion, with structural tailwinds — regulatory changes, technology shifts, or behavioural trends — that make now the right time to build in this space. Key Metrics for a European Series A While every company is different, the following benchmarks represent the median expectations for a competitive European Series A round in 2026: B2B SaaS: €500K–€2M ARR, 15-20% month-over-month growth, net revenue retention above 110%, gross margins above 70%, CAC payback under 18 months. Marketplace: €1M+ in gross merchandise value (GMV) per month, strong take rate, evidence of network effects, repeat purchase rates above 40%. FinTech: Regulatory approvals secured or in progress, €1M+ in transaction volume, clear path to unit profitability, and ideally a banking or payments licence. DeepTech / HealthTech: These sectors are somewhat different — investors may accept lower revenue if the technology is defensible (patents, regulatory moats). However, they expect clear milestones: successful pilots, letters of intent from enterprise customers, or regulatory progress. The Series A Fundraising Process A well-run Series A process follows a structured timeline. Rushing it leads to suboptimal terms; dragging it out drains management attention. Months 1-2: Preparation. Build your investor target list (30-50 funds), prepare your data room, refine your pitch deck, and rehearse your narrative. The data room should include financial […]

Regulatory compliance is devouring three-quarters of medtech companies’ budgets, creating a bottleneck that’s particularly acute for European startups navigating both EU MDR requirements and FDA approvals for global market access. This regulatory maze has become a critical competitive disadvantage, with smaller companies often spending months or years on documentation that could be streamlined through intelligent automation. Against this backdrop, Utrecht-based Guideways has secured over €1.2 million in pre-seed funding to tackle this exact challenge. The round was led by Healthy.Capital and Rising Star Venture Partners, both investors with deep expertise in healthcare technology and regulatory technology convergence. Medtech compliance funding addresses European regulatory gap The investment thesis here is compelling for European venture funds increasingly focused on regulatory technology solutions. Healthy.Capital, which has built a portfolio around healthcare innovation, recognises that compliance automation represents a massive untapped market within the medtech sector. “The regulatory burden on medtech companies has reached unsustainable levels,” explains a partner at Healthy.Capital. “Guideways’ approach to automating FDA approval processes could fundamentally change how European medtech companies scale globally.” Rising Star Venture Partners brings complementary expertise in enterprise software, particularly around workflow automation and document processing. The combination suggests investors see Guideways not just as a medtech play, but as a broader regulatory technology solution that could extend beyond healthcare into other heavily regulated sectors. This investor mix also reflects a growing trend among European VCs to co-invest across sector expertise, combining healthcare domain knowledge with technical automation capabilities. Dutch startup targets global medtech market Guideways’ platform addresses a particular pain point for European medtech companies: the dual challenge of meeting EU MDR compliance whilst simultaneously preparing for FDA submissions. This regulatory arbitrage opportunity is uniquely positioned for European startups, who understand both regulatory frameworks intimately. The company’s AI-driven approach to documentation and approval processes could significantly reduce the 18-24 month timelines typically associated with FDA submissions. For European medtech companies, this acceleration is critical for competing with US counterparts who enjoy geographic proximity to regulators. The funding will primarily support product development and the establishment of regulatory partnerships, with particular focus on building automated workflows that can adapt to evolving compliance requirements. “We’re not just digitising existing processes,” notes a Guideways spokesperson. “We’re reimagining how medtech companies approach regulatory strategy from the ground up.” Utrecht’s position as an emerging European medtech hub, alongside established centres like London and Berlin, provides Guideways with access to both talent and potential customers within the Dutch life sciences ecosystem. This funding round signals growing investor confidence in regulatory technology solutions, particularly those that can bridge European and American market requirements. For the broader European medtech ecosystem, Guideways represents the kind of infrastructure innovation that could level the playing field with Silicon Valley competitors.

TechnoCarbon's innovation, Pierre-Carbone, uses composite technology to turn stone into the first sustainable material to outperform steel and concrete for heavy-duty applications.

Last year I spent 11 hours scrolling through Eventbrite, LinkedIn Events, and random newsletters trying to find startup events worth attending. Found 47 “amazing opportunities.” Went to 8. Got ROI from 2. Here’s the problem: there are over 32,000 startup events globally every year according to UFI Global, and 90% of them are a waste of your calendar and cash. I needed a system. Here’s how I now find high-ROI events in 20 minutes instead of 11 hours. Why Most Founders Suck at Finding the Right Events You know what kills me? Founders who Google “best startup events 2025,” click the first TechCrunch listicle, and drop $3K on a ticket because Web Summit looks cool on LinkedIn. Then they complain events don’t work. The issue isn’t that good startup events don’t exist. It’s that you’re using consumer discovery methods for B2B decisions. Eventbrite is built for yoga classes and birthday parties, not finding where enterprise buyers congregate. LinkedIn Events is 80% webinar spam. Google? Shows you the events with the biggest ad budgets, not the best attendees. According to Cvent research, 67% of trade show attendees represent completely new business prospects. But only if you’re at the RIGHT show. Wrong event selection is the #1 reason founders think “events don’t work.” The events work fine. You’re just showing up to the wrong rooms. Here’s the system I use to find events where actual deals happen. Source #1: Reverse Engineer Where Your Buyers Already Go Stop asking “what startup events should I attend?” Start asking “where do my target customers already hang out?” Different question, different answer. If you sell API infrastructure to DevOps teams, you want KubeCon, not Collision. If you sell HR software to mid-market companies, you want SHRM Annual Conference, not Web Summit. This seems obvious but I see B2B SaaS founders at consumer tech conferences all the time wondering why they’re not closing enterprise deals. Here’s my process: Pull your top 10 customers. Google “[company name] + speaking” and “[company name] + sponsoring.” See which conferences they present at or sponsor. That’s where their peers are. That’s your target event list. Takes 15 minutes, beats 11 hours of blind searching. For finding these industry-specific events, I use trade association directories. Every vertical has one: SBA.gov has a comprehensive list, or search “[your industry] + trade association” and check their events calendar. These are where buyers go, not tourists. Source #2: Follow the Money (Where VCs and Partners Speak) Want to find quality startup events? Track where the money shows up. Check Crunchbase for your target investors and see where they’re listed as speakers. Use LinkedIn to follow VCs and watch what events they post about attending. I have a simple spreadsheet: 20 investors I want to meet, their LinkedIn profiles bookmarked, notifications on. When they post “Looking forward to speaking at [Event],” that event goes on my shortlist. If three investors I want to meet are all going to the same conference, that’s not coincidence. That’s signal. Pro tip: Most VCs announce speaking gigs 4-6 weeks before the event. Set Google Alerts for “[Investor Name] + speaking” to catch these early. Registration is cheaper and you can book meetings with them before their calendars fill up. Here’s how I turn those meetings into actual conversations. Source #3: Use a Real B2B Event Discovery Platform After burning months on consumer event platforms, I switched to Sesamers for B2B event discovery. It’s built specifically for founders looking for business events, not birthday party planners looking for venues. The difference? You can filter by industry (API/SaaS, fintech, healthcare tech, etc.), attendee profile (VCs, enterprise buyers, distribution partners), and event size. You can see who actually attended past editions before buying a $2K ticket. You can track which events your network is going to. Game changer. I have filters saved for “B2B SaaS events in North America with 500-2000 attendees” and “fintech conferences with VC attendance.” One click, boom, my quarterly event shortlist. Beats the hell out of scrolling Eventbrite for three hours. Here’s my full system for tracking events without losing my mind. Source #4: Mine Your Network (The 80/20 of Event Discovery) The fastest way to find startup events worth attending? Ask founders who are two years ahead of you what they go to. Not “what events do you recommend” (they’ll just name drop). Ask “what’s the ONE event where you closed your biggest deal last year?” I send this exact message to 5-10 founders in my industry every quarter: “Hey [Name], building my 2025 event calendar. What’s the ONE conference that drove the most revenue for [their company] last year? And which one was overhyped?” Two-question email, 90% response rate, pure gold. Set up a simple Notion database or Airtable with: Event name, Recommended by, Why they liked it, Approximate ROI. After 6 months you’ll have a curated list of events that actually work for your specific business model. Worth more than any “Top 50 Startup Events” listicle. Another hack: Join Slack communities for your industry (SaaStr has great ones for SaaS founders). Search the channels for “conference” or “event” and read what people actually say, not what sponsors promote. Real founders complaining or praising = real signal. Source #5: Check the Attendee List Before You Buy This is my non-negotiable filter. Before I buy any ticket over $500, I demand to see the attendee list or at least historical attendance data. If the organizer won’t share it? Red flag. They’re hiding something. Some events publish attendee lists 6-8 weeks before (especially B2B trade shows). Others have “matchmaking platforms” where you can browse who’s registered. If the event has neither, email the organizers directly and ask for: average attendee seniority, percentage of attendees by role (founder/investor/corporate), and top companies that attended last year. I track this in Sesamers because they aggregate historical data on major B2B events—attendance numbers, speaker quality ratings, and which types of companies typically show up. Saves me from buying tickets to events that […]